Produkty 5615-45-2

CAS 5615-45-2 występuje w naszej ofercie pod nazwami: 3,17-Dioxo-4-androsten-11alpha-yl hydrogen succinate, 11a-Hydroxy-3,17-Dioxo-Androsten-(4)-Hydrogensuccinat. Oferty producentów: Chemat Brand. Dostępne opakowania: on request.

3,17-Dioxo-4-androsten-11alpha-yl hydrogen succinate
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
11a-Hydroxy-3,17-Dioxo-Androsten-(4)-Hydrogensuccinat
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4-[[(8S,9S,10R,11R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]oxy]-4-oxobutanoic acid (CAS 5615-45-2) to związek chemiczny o wzorze sumarycznym C23H30O6 i masie molowej 402.5 g/mol. Nazwa systematyczna IUPAC: 4-[[(8S,9S,10R,11R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]oxy]-4-oxobutanoic acid. InChIKey: NOALTCHZPRZGCP-SUMFRYMYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H30O6
Masa molowa402.5 g/mol
Nazwa IUPAC4-[[(8S,9S,10R,11R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]oxy]-4-oxobutanoic acid
InChIKeyNOALTCHZPRZGCP-SUMFRYMYSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@@H](C[C@]4([C@H]3CCC4=O)C)OC(=O)CCC(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3,17-Dioxo-4-androsten-11alpha-yl hydrogen succinate, NOALTCHZPRZGCP-SUMFRYMYSA-N, 4-[(3,17-Dioxoandrost-4-en-11-yl)oxy]-4-oxobutanoic acid #
Izomery (ten sam wzór sumaryczny)
(9S,10R)-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaen-3-ol C23H30O6
[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O6
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O6
(7R,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylic acid C23H30O6
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-8-carboxylic acid C23H30O6
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O6
[2-[(9S,10R,11S,13S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,9,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O6
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C23H30O6
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O6
[2-[(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-en-14-yl]-2-oxoethyl] acetate C23H30O6
methyl 7-[(1S,2S,3S,5R)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-4-phenoxybut-1-enyl]cyclopentyl]hepta-4,5-dienoate C23H30O6
[2-[(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O6